• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Azole and Amphotericin B MIC Values against : High Agreement between Spectrophotometric and Visual Readings Using the EUCAST EDef 9.3.2 Procedure.唑类和两性霉素 B 的 MIC 值对:使用 EUCAST EDef 9.3.2 程序进行分光光度法和目视读数的高度一致。
Antimicrob Agents Chemother. 2020 Dec 16;65(1). doi: 10.1128/AAC.01693-20.
2
Spectrophotometric azole and amphotericin B MIC readings against Aspergillus fumigatus sensu lato using the EUCAST 9.3.2 methodology. Are ≥90 and ≥95% fungal growth inhibition endpoints equally suitable?采用 EUCAST 9.3.2 方法对烟曲霉广义种进行分光光度唑类药物和两性霉素 B MIC 读数。是否 90%和 95%真菌生长抑制终点同样适用?
Med Mycol. 2021 Dec 8;60(1). doi: 10.1093/mmy/myab072.
3
Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant Section Clinical Isolates.梯度浓度条法与 EUCAST 方法测定四种唑类药物和两性霉素 B 对唑类敏感和耐药临床分离株 MIC 值的比较。
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.01597-19.
4
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato.梯度扩散带法检测烟曲霉及其近缘种的唑类药物耐药性。
Mycoses. 2023 Mar;66(3):196-201. doi: 10.1111/myc.13541. Epub 2022 Nov 2.
5
In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.ASP2397对具有或不具有获得性唑类耐药机制的曲霉分离株的体外活性。
Antimicrob Agents Chemother. 2015 Nov 9;60(1):532-6. doi: 10.1128/AAC.02336-15. Print 2016 Jan.
6
Spectrophotometric detection of azole-resistant Aspergillus fumigatus with the EUCAST broth microdilution method: is it time for automated MIC reading of EUCAST antifungal susceptibility testing of Aspergillus species?EUCAST 肉汤微量稀释法检测唑类耐药烟曲霉:是否到了自动读取 EUCAST 曲霉属抗真菌药敏试验 MIC 的时候了?
J Antimicrob Chemother. 2022 Apr 27;77(5):1296-1300. doi: 10.1093/jac/dkac046.
7
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).如何根据修订后的临床折点 v.10.0 欧洲抗菌药物敏感性试验委员会 (EUCAST) 来解释抗真菌化合物的 MIC 值。
Clin Microbiol Infect. 2020 Nov;26(11):1464-1472. doi: 10.1016/j.cmi.2020.06.007. Epub 2020 Jun 17.
8
Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.比较 Sensititre YeastOne 和 CLSI M38-A2 微量稀释法测定两性霉素 B、伊曲康唑、伏立康唑和泊沙康唑对曲霉属的活性。
J Clin Microbiol. 2018 Sep 25;56(10). doi: 10.1128/JCM.00780-18. Print 2018 Oct.
9
Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.荷兰野生型、TR34/L98H 和 TR46/Y121F/T289A 烟曲霉分离株的唑类、多烯和棘白菌素 MIC 分布。
J Antimicrob Chemother. 2015 Jan;70(1):178-81. doi: 10.1093/jac/dku364. Epub 2014 Oct 9.
10
Spectrophotometric reading of EUCAST antifungal susceptibility testing of Aspergillus fumigatus.EUCAST 烟曲霉抗真菌药敏试验的分光光度读数。
Clin Microbiol Infect. 2017 Feb;23(2):98-103. doi: 10.1016/j.cmi.2016.10.017. Epub 2016 Oct 25.

引用本文的文献

1
Susceptibilities of Worldwide Isolates of Intrapulmonary Species and Important Species in Sterile Body Sites against Important Antifungals: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2017-2020.肺部定植菌属和重要无菌部位定植菌属对重要抗真菌药物的敏感性:来自 2017-2020 年抗微生物药物测试领导和监测计划的数据。
Microbiol Spectr. 2022 Dec 21;10(6):e0296522. doi: 10.1128/spectrum.02965-22. Epub 2022 Oct 31.
2
Calcimycin Inhibits and by Targeting the Prp8 Intein Splicing.钙离子载体A23187通过靶向Prp8内含肽剪接来抑制和 。(原文中“and by Targeting the Prp8 Intein Splicing”前似乎少了内容,导致翻译不太完整准确)
ACS Infect Dis. 2022 Sep 9;8(9):1851-1868. doi: 10.1021/acsinfecdis.2c00137. Epub 2022 Aug 10.
3
EUCAST-Obtained Olorofim MICs against Aspergillus and Scedosporium Species and Lomentospora prolificans Showed High Agreements between Visual Inspection and Spectrophotometric Readings.EUCAST 获得的曲霉属和枝顶孢属及繁茂枝顶孢菌的奥洛氟米 MIC 结果,目测与分光光度读取法之间显示出高度一致性。
Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0084922. doi: 10.1128/aac.00849-22. Epub 2022 Aug 4.
4
In Vitro Activity of Amphotericin B in Combination with Colistin against Fungi Responsible for Invasive Infections.两性霉素B与黏菌素联合应用对引起侵袭性感染的真菌的体外活性
J Fungi (Basel). 2022 Jan 26;8(2):115. doi: 10.3390/jof8020115.
5
Spectrophotometric detection of azole-resistant Aspergillus fumigatus with the EUCAST broth microdilution method: is it time for automated MIC reading of EUCAST antifungal susceptibility testing of Aspergillus species?EUCAST 肉汤微量稀释法检测唑类耐药烟曲霉:是否到了自动读取 EUCAST 曲霉属抗真菌药敏试验 MIC 的时候了?
J Antimicrob Chemother. 2022 Apr 27;77(5):1296-1300. doi: 10.1093/jac/dkac046.
6
Azole-Resistant Aspergillus fumigatus Clinical Isolate Screening in Azole-Containing Agar Plates (EUCAST E.Def 10.1): Low Impact of Plastic Trays Used and Poor Performance in Cryptic Species.含唑类药物琼脂平板中唑类耐药烟曲霉临床分离株的筛选(EUCAST E.Def 10.1):塑料托盘的使用影响较小,但在隐匿种中的表现不佳。
Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0048221. doi: 10.1128/AAC.00482-21.
7
Updated EUCAST Clinical Breakpoints against , Implications for the Clinical Microbiology Laboratory.针对……的更新后的欧盟CAST临床断点,对临床微生物实验室的影响。 (你提供的原文“against”后面缺少具体内容,以上翻译是根据现有内容尽量完善后的结果)
J Fungi (Basel). 2020 Dec 6;6(4):343. doi: 10.3390/jof6040343.

本文引用的文献

1
Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain.西班牙临床烟曲霉分离株的唑类耐药性调查。
Clin Microbiol Infect. 2021 Aug;27(8):1170.e1-1170.e7. doi: 10.1016/j.cmi.2020.09.042. Epub 2020 Oct 1.
2
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).如何根据修订后的临床折点 v.10.0 欧洲抗菌药物敏感性试验委员会 (EUCAST) 来解释抗真菌化合物的 MIC 值。
Clin Microbiol Infect. 2020 Nov;26(11):1464-1472. doi: 10.1016/j.cmi.2020.06.007. Epub 2020 Jun 17.
3
Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management.烟曲霉中的三唑类耐药性:患者管理的最新见解和挑战。
Clin Microbiol Infect. 2019 Jul;25(7):799-806. doi: 10.1016/j.cmi.2018.11.027. Epub 2018 Dec 21.
4
Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study.伏立康唑耐药与侵袭性曲霉病患者死亡率的相关性:一项多中心回顾性队列研究。
Clin Infect Dis. 2019 Apr 24;68(9):1463-1471. doi: 10.1093/cid/ciy859.
5
Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study).西班牙前瞻性监测唑类药物耐药性研究(FILPOP2 研究)中分离的霉菌的分子鉴定和药敏试验。
Antimicrob Agents Chemother. 2018 Aug 27;62(9). doi: 10.1128/AAC.00358-18. Print 2018 Sep.
6
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.曲霉病的诊断和治疗:2017 年 ESCMID-ECMM-ERS 指南执行摘要。
Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.
7
Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.临床烟曲霉分离株对艾沙康唑的敏感性以及艾沙康唑剂量递增治疗最低抑菌浓度升高的分离株的可行性。
J Antimicrob Chemother. 2018 Jan 1;73(1):263. doi: 10.1093/jac/dkx425.
8
Animal Models for Studying Triazole Resistance in Aspergillus fumigatus.研究烟曲霉唑类耐药性的动物模型。
J Infect Dis. 2017 Aug 15;216(suppl_3):S466-S473. doi: 10.1093/infdis/jix222.
9
Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species.用于检测和推断曲霉属物种中唑类抗真菌药物耐药表型的分子工具
Clin Microbiol Rev. 2017 Oct;30(4):1065-1091. doi: 10.1128/CMR.00095-16.
10
The global problem of antifungal resistance: prevalence, mechanisms, and management.全球抗真菌耐药性问题:流行率、机制和管理。
Lancet Infect Dis. 2017 Dec;17(12):e383-e392. doi: 10.1016/S1473-3099(17)30316-X. Epub 2017 Jul 31.

唑类和两性霉素 B 的 MIC 值对:使用 EUCAST EDef 9.3.2 程序进行分光光度法和目视读数的高度一致。

Azole and Amphotericin B MIC Values against : High Agreement between Spectrophotometric and Visual Readings Using the EUCAST EDef 9.3.2 Procedure.

机构信息

Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.

出版信息

Antimicrob Agents Chemother. 2020 Dec 16;65(1). doi: 10.1128/AAC.01693-20.

DOI:10.1128/AAC.01693-20
PMID:33020164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7927860/
Abstract

The EUCAST EDef 9.3.2 procedure recommends visual readings of azole and amphotericin B MICs against spp. Visual determination of MICs may be challenging. In this work, we aim to obtain and compare visual and spectrophotometric MIC readings of azoles and amphotericin B against isolates. A total of 847 isolates ( [ = 828] and cryptic species [ = 19]) were tested against amphotericin B, itraconazole, voriconazole, posaconazole, and isavuconazole using the EUCAST EDef 9.3.2 procedure. Isolates were classified as susceptible or resistant/non-wild type according to the 2020 updated breakpoints. The area of technical uncertainty for the azoles was defined in the updated breakpoints. Visual and spectrophotometric (fungal growth reduction of >95% compared to the control, read at 540 nm) MICs were compared. Essential (±1 2-fold dilution) and categorical agreements were calculated. Overall, high essential (97.1%) and categorical (99.6%) agreements were found. We obtained 100% categorical agreements for amphotericin B, itraconazole, and posaconazole, and consequently, no errors were found. Categorical agreements were 98.7 and 99.3% for voriconazole and isavuconazole, respectively. Most of the misclassifications for voriconazole and isavuconazole were found to be associated with MIC results falling either in the area of technical uncertainty or within one 2-fold dilution above the breakpoint. The resistance rate was slightly lower when the MICs were obtained by spectrophotometric readings. However, all relevant mutants were correctly classified as resistant. Spectrophotometric determination of azole and amphotericin B MICs against isolates may be a convenient alternative to visual endpoint readings.

摘要

EUCAST EDef 9.3.2 程序建议使用视觉方法读取唑类和两性霉素 B 对 spp 的 MIC 值。然而,视觉 MIC 值的确定可能具有挑战性。在这项工作中,我们旨在获得并比较唑类和两性霉素 B 对 分离株的视觉和分光光度 MIC 值读数。使用 EUCAST EDef 9.3.2 程序,对总共 847 株 分离株([=828]和隐种[=19])进行了两性霉素 B、伊曲康唑、伏立康唑、泊沙康唑和伊沙康唑的检测。根据 2020 年更新的折点,将分离株分类为敏感或耐药/非野生型。在更新的折点中定义了唑类药物的技术不确定区。比较了视觉和分光光度(与对照相比,真菌生长减少>95%,在 540nm 处读取)MIC 值。计算了基本(±1 倍稀释)和分类一致性。总体而言,发现了高基本(97.1%)和分类(99.6%)一致性。我们获得了两性霉素 B、伊曲康唑和泊沙康唑 100%的分类一致性,因此没有发现错误。伏立康唑和伊沙康唑的分类一致性分别为 98.7%和 99.3%。伏立康唑和伊沙康唑的大多数错误分类与 MIC 结果落在技术不确定区或折点上方一个 2 倍稀释范围内有关。通过分光光度法获得 MIC 值时,耐药率略低。然而,所有相关的 突变体均被正确分类为耐药。对 分离株的唑类和两性霉素 B MIC 值进行分光光度测定可能是视觉终点读数的一种方便替代方法。